MARKET WIRE NEWS
  1. Home
  2. Stock
  3. ATRA
  4. News
ATRA
Quote
Short
News
Articles
Message Board

Atara Biotherapeutics Inc. (NASDAQ : ATRA ) News

Atara Biotherapeutics Inc. (NASDAQ: ATRA) News Releases

ATRA News Releases
ATRA : NASDAQ
Business Wire
Atara Biotherapeutics Announces Third Quarter Financial Results and Operational Progress
ATRA : NASDAQ
US Earnings Reports
Expected US Company Earnings on Tuesday, November 11th, 2025
ATRA : NASDAQ
PR Newswire
Pierre Fabre Pharmaceuticals Announces Transfer from Atara Biotherapeutics of the Biologics License Application (BLA) for Tabelecleucel as Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD)
ATRA : NASDAQ
Business Wire
Atara Biotherapeutics Announces Changes to Its Board of Directors
ATRA : NASDAQ
SeekingAlpha
Atara Biotherapeutics GAAP EPS of $0.19, revenue of $17.58M
ATRA : NASDAQ
Business Wire
Atara Biotherapeutics Announces Second Quarter Financial Results and Operational Progress
ATRA : NASDAQ
US Earnings Reports
Expected US Company Earnings on Monday, August 11th, 2025
ATRA : NASDAQ
US Earnings Reports
Expected earnings - Atara Biotherapeutics Inc.
ATRA : NASDAQ
PRISM News
FDA Accepts Atara Biotherapeutics' BLA for Tab-cel(R)
ATRA : NASDAQ
SeekingAlpha
Atara gets FDA priority review for Tabelecleucel application
Back to Start

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.